stockNASDAQ: HALO • 28 Days Updates
Halozyme Therapeutics Inc. (HALO)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Halozyme Therapeutics Inc. (HALO) is a publicly traded company operating within the Health Care sector.
Investor Relations:ir.halozyme.com
Price & Performance Trajectory
Halozyme Therapeutics Inc.NASDAQ: HALO
Latest Close
$110.42
28 Days Updates Trajectory
Showing Closing Date Range from Sep 11 to Oct 9, 2026.Loading trajectory chart...
Click metric scorecards below to toggle price, return %, range & volume curvesHALO session performance
✓ Latest Close USD
$110.42
Latest session close
+$3.22vs period start
Period Return % % GAIN
+3%
Net period trajectory
Cumulative ReturnNormalized
High / Low Range SPREAD
$116.85 / $105.5
Period range envelope
$11.35channel spread
Total Volume SHARES
51.62M
Period turnover
Avg: 2.58M/dLiquidity
Historical Session Ledger
Daily open, high, low, and close prices with volume and period returns.
Historical Quotes & Breakdown(20 dates)
| Date | Close (USD) | Return % | High | Low | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | $110.42 | +0.53% | $112.65 | $109.70 | 1.85M |
| Oct 08, 2026 | $109.84 | -0.86% | $110.63 | $107.41 | 2.44M |
| Oct 07, 2026 | $110.79 | +0.98% | $114.00 | $110.16 | 2.18M |
| Oct 06, 2026 | $109.72 | +1.30% | $111.25 | $107.43 | 1.77M |
| Oct 05, 2026 | $108.31 | -1.41% | $109.87 | $107.69 | 1.45M |
| Oct 02, 2026 | $109.86 | +2.73% | $109.99 | $106.65 | 2.60M |
| Oct 01, 2026 | $106.94 | -3.13% | $110.50 | $106.84 | 2.33M |
| Sep 30, 2026 | $110.40 | -1.04% | $112.45 | $110.35 | 3.52M |
| Sep 29, 2026 | $111.56 | -1.18% | $114.52 | $111.03 | 2.87M |
| Sep 28, 2026 | $112.89 | -0.89% | $113.94 | $112.10 | 2.24M |
| Sep 25, 2026 | $113.90 | -1.15% | $115.63 | $113.43 | 1.96M |
| Sep 23, 2026 | $112.44 | -2.34% | $116.85 | $112.18 | 2.70M |
| Sep 22, 2026 | $115.13 | +3.30% | $115.18 | $110.95 | 4.13M |
| Sep 21, 2026 | $111.45 | -0.89% | $113.47 | $111.05 | 2.88M |
| Sep 18, 2026 | $112.45 | +2.53% | $112.66 | $109.38 | 10.18M |
Page 1 of 2